- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about mRNA
Recent news which mentions mRNA
Bill Gates Says 'Next Pandemic Can Emerge Anywhere' And The World Isn't Prepared: 'We Can't Afford To Get Caught Flat-Footed Again'
February 24, 2025
From Benzinga
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
February 24, 2025
From Benzinga
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
February 20, 2025
Tickers
MRNA
From Motley Fool
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
February 18, 2025
From Benzinga
From Benzinga
From Benzinga
Brutal Price Target Cut: Moderna Slashed by 60%
February 18, 2025
From Wall Street Pit
Health Insurance ETFs in Focus as RFK Jr Takes Over HHS
February 17, 2025
From Benzinga
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
February 14, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 14, 2025
From Benzinga
Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 14, 2025
From Benzinga
Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
February 14, 2025
From Benzinga
Dow Jumps Over 300 Points Following Recent Inflation Data; Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
February 14, 2025
From Benzinga
Palo Alto Networks, Moderna And 3 Stocks To Watch Heading Into Friday
February 14, 2025
From Benzinga
US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'
February 14, 2025
From Benzinga
Earnings Scheduled For February 14, 2025
February 14, 2025
From Benzinga
Moderna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 14, 2025
From Benzinga
Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch
February 13, 2025
From Benzinga
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
February 13, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 11, 2025
From Benzinga
From Benzinga
Moderna Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
February 11, 2025
Tickers
MRNA
From Benzinga
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
February 10, 2025
From Benzinga
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
February 10, 2025
From Benzinga
2 Biotech Stocks to Buy Hand Over Fist in February
February 09, 2025
From Motley Fool
Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
February 09, 2025
From Benzinga
3 Beaten-Down Stocks That Aren't Worth Buying on the Dip
February 08, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.